https://wsxzaq.shinyapps.io/wsxzaq_nomogram/). The score has been verified among three independent external cohorts (GSE13213, GSE68465 and GSE72094), and is still an independent risk factor for lung adenocarcinoma. In addition, among the other 6 cancers, the OS prognosis of high and low-risk groups of PRS is different (P < 0.05). Our research results have screened multiple platelet differential genes with clinical significance and constructed a meaningful prognostic risk score (PRS)." name="description"> Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression - Figure f3 | Aging
← Back
Research Paper Volume 13, Issue 6 pp 8706—8719

Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression

class="figure-viewer-img"

Figure 3. Development of the nomogram based on PRS and clinical features. (A–D) The receiver operating characteristic (ROC) curve of OS in TCGA, GSE13213, GSE68465 and GSE72094 cohort. (E) ROC curve of the nomogram based on PRS in TCGA. (F) The nomogram based on PRS in TCGA. (G–I) 1, 3 and 5-year calibration curves of nomogram in TCGA.